AHR and Alzheimer disease: Interestingly, topical phosphodiesterase (PDE) 4 inhibitors and aryl hydrocarbon receptor (AhR) agonists are also effective for AD skin lesions in terms of the restoration of skin barrier function and the regulation of inflammatory cytokine production [15,16,17].